Literature DB >> 22398431

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency.

Cedric Hermans, Stéphane Eeckhoudt, Catherine Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22398431     DOI： 10.1160/TH11-11-0788

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  The use of direct oral anticoagulants in inherited thrombophilia.

Authors:  Jessica W Skelley; C Whitney White; Angela R Thomason
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis.

Authors:  Neethu Menon; Ravi Sarode; Ayesha Zia
Journal:  Blood Adv       Date:  2018-01-23

3.  Simultaneous Left Ventricular and Deep Vein Thrombi Caused by Protein C Deficiency.

Authors:  Harufumi Maki; Motohiro Nishiyama; Motoaki Shirakawa
Journal:  Case Rep Med       Date:  2017-01-17

4.  Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia.

Authors:  Alessandra Serrao; Benedetta Lucani; Davide Mansour; Antonietta Ferretti; Erminia Baldacci; Cristina Santoro; Robin Foà; Antonio Chistolini
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

Review 5.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.